Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 7
1976 14
1977 22
1978 18
1979 11
1980 16
1981 21
1982 21
1983 31
1984 39
1985 35
1986 47
1987 54
1988 41
1989 60
1990 57
1991 79
1992 67
1993 70
1994 75
1995 95
1996 96
1997 64
1998 68
1999 82
2000 84
2001 70
2002 96
2003 70
2004 84
2005 84
2006 122
2007 130
2008 149
2009 151
2010 169
2011 176
2012 203
2013 232
2014 242
2015 198
2016 220
2017 249
2018 213
2019 213
2020 96
Text availability
Article attribute
Article type
Publication date

Search Results

3,963 results
Results by year
Filters applied: . Clear all
Page 1
Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review.
Wang W, Zhou H, Liu L. Wang W, et al. Eur J Med Chem. 2018 Oct 5;158:502-516. doi: 10.1016/j.ejmech.2018.09.027. Epub 2018 Sep 13. Eur J Med Chem. 2018. PMID: 30243154 Review.
MTX benefits a large number of RA patients but partially suffered from side effects. A variety of side effects can be associated with MTX when treating RA patients, from mild to severe or discontinuation of the treatment. ...The management of MTX
MTX benefits a large number of RA patients but partially suffered from side effects. A variety of side effects can be a
Efficacy and adverse effects of methotrexate compared with azathioprine in the antisynthetase syndrome.
Casal-Dominguez M, Pinal-Fernandez I, Huapaya J, Albayda J, Paik JJ, Johnson C, Silhan L, Mammen AL, Danoff SK, Christopher-Stine L. Casal-Dominguez M, et al. Clin Exp Rheumatol. 2019 Sep-Oct;37(5):858-861. Epub 2019 Apr 29. Clin Exp Rheumatol. 2019. PMID: 31074729 Free article.
OBJECTIVES: To study the efficacy in terms of muscle strength, and corticosteroid tapering as well as the prevalence of adverse effects in patients with the antisynthetase syndrome (ASyS) treated with azathioprine (AZA) compared to those treated with methotrexate ( …
OBJECTIVES: To study the efficacy in terms of muscle strength, and corticosteroid tapering as well as the prevalence of adverse ef
The toxicity of methotrexate in male fertility and paternal teratogenicity.
Gutierrez JC, Hwang K. Gutierrez JC, et al. Expert Opin Drug Metab Toxicol. 2017 Jan;13(1):51-58. doi: 10.1080/17425255.2017.1230198. Epub 2016 Sep 9. Expert Opin Drug Metab Toxicol. 2017. PMID: 27590039 Review.
Given the unclear evidence, patients treated with MTX must be counseled on the likelihood of adverse effects of MTX and role of sperm cryopreservation. Future studies are needed to help elucidate the unclear evidence of MTX effects on mal …
Given the unclear evidence, patients treated with MTX must be counseled on the likelihood of adverse effects of MTX
[Adverse effects of high-dose methotrexate therapy].
Sun Q, Xie Y, Zhao WH, Hua Y, Wu PH, Li S, Lu XT. Sun Q, et al. Zhongguo Dang Dai Er Ke Za Zhi. 2017 Jul;19(7):781-785. doi: 10.7499/j.issn.1008-8830.2017.07.010. Zhongguo Dang Dai Er Ke Za Zhi. 2017. PMID: 28697831 Free PMC article. Chinese.
The adverse effects of various systems were analyzed according to the WHO criteria for the classification of adverse effects of anticancer drugs. ...Serious adverse effects were only seen in the blood system and digestive system. Compared …
The adverse effects of various systems were analyzed according to the WHO criteria for the classification of adverse
Effect of methotrexate on bone and wound healing.
Pountos I, Giannoudis PV. Pountos I, et al. Expert Opin Drug Saf. 2017 May;16(5):535-545. doi: 10.1080/14740338.2017.1310839. Epub 2017 Mar 29. Expert Opin Drug Saf. 2017. PMID: 28332422 Review.
Methotrexate (MTX) is one of the most commonly used disease modifying drugs administered for wide spectrum of conditions. Through the expansion of the indications of MTX use, an increasing number of patients nowadays attend orthopaedic departments receiving this pha …
Methotrexate (MTX) is one of the most commonly used disease modifying drugs administered for wide spectrum of conditions. Through the …
[A Survey of the Adverse Effects and Influence of Concomitant Drugs for Methotrexate Intrathecal Administration].
Uchiyama M, Ueno M, Takamatsu Y, Matsuo K, Imakyure O, Kamimura H. Uchiyama M, et al. Yakugaku Zasshi. 2018;138(1):111-115. doi: 10.1248/yakushi.17-00122. Yakugaku Zasshi. 2018. PMID: 29311456 Free article. Japanese.
In general, the intraventricular administration of cytotoxic antitumor drugs provides a high drug concentration in the cerebrospinal fluid with a reduced risk of systemic adverse reactions. ...We must consider drug interactions with combination therapy as a potential fact …
In general, the intraventricular administration of cytotoxic antitumor drugs provides a high drug concentration in the cerebrospinal fluid …
How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
Cansu DÜ, Teke HÜ, Bodakçi E, Korkmaz C. Cansu DÜ, et al. Clin Rheumatol. 2018 Dec;37(12):3419-3425. doi: 10.1007/s10067-018-4242-8. Epub 2018 Jul 28. Clin Rheumatol. 2018. PMID: 30056523
Low-dose methotrexate (ld-MTX) that is administered during rheumatoid arthritis (RA) treatment has hematological adverse effects such as pancytopenia, although rare. Although well-established and widely used for hematological adverse effects cau …
Low-dose methotrexate (ld-MTX) that is administered during rheumatoid arthritis (RA) treatment has hematological adverse ef
Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration.
Bianchi G, Caporali R, Todoerti M, Mattana P. Bianchi G, et al. Adv Ther. 2016 Mar;33(3):369-78. doi: 10.1007/s12325-016-0295-8. Epub 2016 Feb 4. Adv Ther. 2016. PMID: 26846283 Free PMC article. Review.
This is true both in MTX-naive patients with early RA, and in patients who switch from MTX OR to MTX SC due to previous treatment failure, lack of efficacy and/or adverse events. Finally, MTX SC has a better tolerability profile than MTX
This is true both in MTX-naive patients with early RA, and in patients who switch from MTX OR to MTX SC due to previous …
[Methotrexate-associated lymphoproliferative disorders: clinical aspects].
Tokuhira M, Kizaki M. Tokuhira M, et al. Rinsho Ketsueki. 2019;60(8):932-943. doi: 10.11406/rinketsu.60.932. Rinsho Ketsueki. 2019. PMID: 31484893 Japanese.
Two-thirds of MTX-LPDs regresses after MTX withdrawal with the higher incidence in Japanese patients, MTX-LPDs consist of various subtypes of LPDs, the feature of each LPD such as the regressive rate, relapse/regrowth rate, and prognosis, widely varies. ...Be …
Two-thirds of MTX-LPDs regresses after MTX withdrawal with the higher incidence in Japanese patients, MTX-LPDs consist …
Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature.
Fragoulis GE, Conway R, Nikiphorou E. Fragoulis GE, et al. Rheumatology (Oxford). 2019 Nov 1;58(11):1900-1906. doi: 10.1093/rheumatology/kez337. Rheumatology (Oxford). 2019. PMID: 31504978 Review.
MTX, which is the anchor-drug for the treatment of RA, has been associated with lung injury and in particular with MTX-related pneumonitis (M-pneu). ...On the other hand, there are data suggesting that clinicians should be cautious when commencing MTX in pati
MTX, which is the anchor-drug for the treatment of RA, has been associated with lung injury and in particular with MTX-related
3,963 results
Jump to page
Feedback